Evidence map›Paper›PMID 28550390›Full record

ArticleClinical rheumatology2017

Clinical patterns and characteristics of ankylosing spondylitis in China.

Qiaoxia Qian, Xia Xu, Hongjun He, Hengdong Ji, Hui Zhang, Yue Ding, Sheng-Ming Dai, Yaohong Zou, Qi Zhu, Chengde Yang and 16 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A Mechanism Underlying Sex-Associated Differences in Ankylosing Spondylitis: Troponin C2, Fast Skeletal Type (TNNC2) and Calcium Signaling Pathway.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Observational
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 15 institutions in 2 countries.

Qiaoxia QianState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
Xia XuDivision of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.
Hongjun HeDivision of Rheumatology, Taixing People's Hospital, Taizhou, Jiangsu Province, China.
Hengdong JiDivision of Rheumatology, Taizhou People's Hospital, Taizhou, Jiangsu Province, China.
Hui ZhangState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
Yue DingState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
Sheng-Ming DaiDepartment of Rheumatology and Immunology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Yaohong ZouDivision of Rheumatology and Immunology, Wuxi People's Hospital, Wuxi, Jiangsu Province, China.
Qi ZhuInstitute of Arthritis Research, Shanghai Academy of Chinese Medical Sciences, Guanghua Integrative Medicine Hospital, Shanghai, China.
Chengde YangDivision of Rheumatology, Ruijin Hospital, Shanghai Jiaotong University Schools of Medicine, Shanghai, China.
Shuang YeDivision of Rheumatology, Renji Hospital, Shanghai Jiaotong University Schools of Medicine, Shanghai, China.
Lindi JiangDepartment of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Jian-Ping TangDivision of Rheumatology and Immunology, Tongji Hospital of Tongji University School of Medicine, Shanghai, China.
Qiang TongDivision of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.
Dongyi HeInstitute of Arthritis Research, Shanghai Academy of Chinese Medical Sciences, Guanghua Integrative Medicine Hospital, Shanghai, China.
Dongbao ZhaoDivision of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.
Yuan LiState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
Yanyun MaState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
Jingru ZhouState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
Ziyu YuanFudan-Taizhou Institute of Health Sciences, Taizhou, Jiangsu Province, China.
Juan ZhangFudan-Taizhou Institute of Health Sciences, Taizhou, Jiangsu Province, China.
Li JinState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
Xiaodong ZhouUniversity of Texas-McGovern Medical School, Houston, TX, USA.
John D ReveilleUniversity of Texas-McGovern Medical School, Houston, TX, USA.
Hejian ZouDivision of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China. hjzou@fudan.edu.cn.
Jiucun WangState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China. jcwang@fudan.edu.cn.
Fudan University · CNState Key Laboratory of Genetic EngineeringSecond Military Medical University · CNShanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine · CNThe University of Texas Health Science Center at Houston · USChanghai Hospital · CNHuashan Hospital · CNNantong University · CNRenji Hospital · CNRuijin Hospital · CNShanghai Jiao Tong University · CNTaixing People's Hospital · CNTongji Hospital · CNWuxi People's Hospital · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aimed to determine whether unique clinical patterns of AS may exist in China, specifically to explore the different clinical manifestations caused by gender, HLA-B27 status, and age at disease onset. The multicenter cross-sectional survey was conducted and 1251 patients were enrolled across China, representing a broad spectrum of Chinese AS patients. The mean age at onset and diagnosis were 29.2 (11.4) and 33.5 (12.6) years, respectively. The male/female ratio was 2.7:1. Acute anterior uveitis (AAU) was experienced in 10.3% of AS patients and 9.1% patients had juvenile-onset AS (JoAS). Men were significantly younger at onset and diagnosis and showed a higher frequency of HLA-B27 positivity, JoAS, and AAU than women. HLA-B27-positive patients had a younger age of onset than HLA-B27-negative patients. HLA-B27-positive patients were nearly three times as likely to develop AAU than negative patients (P = 0.04). JoAS patients had a family history of AS more often than adult-onset AS (AoAS) patients, and 4.9% of JoAS patients underwent surgical treatments, a rate more than six times that of AoAS patients (P = 0.01). Men had higher levels of C-reactive protein than women, as did HLA-B27 positives compared to negative patients, and JoAS compared to AoAS (all P < 0.05). The clinical patterns of our AS patients were similar to those in other studies in non-Chinese cohort: (1) the age at onset was 29.2 (11.4) years, which was older than found in other studies; (2) men were more likely be HLA-B27 carriers than women; and (3) AAU was less common in Chinese patients.

Indexed as

AdolescentAdultAge of OnsetChinaCross-Sectional StudiesFemaleHLA-B27 AntigenHumansMaleMiddle AgedSex FactorsSpondylitis, AnkylosingYoung AdultHLA-B27 AntigenAnkylosing spondylitisClinical manifestationsHLA-B27

Identifiers

PMID28550390
OpenAlexW2618526566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.